1887

Chapter 29 : Human Herpesviruses 6, 7, and 8

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Human Herpesviruses 6, 7, and 8, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555819156/9781555819149.ch29-1.gif /docserver/preview/fulltext/10.1128/9781555819156/9781555819149.ch29-2.gif

Abstract:

Human herpesvirus 6 (HHV-6A and -6B variants), human herpesvirus 7 (HHV-7), and human herpesvirus 8 (HHV-8) were the last three herpesviruses identified, from 1986 to 1994 (1–3). HHV-6 and HHV-7 are ubiquitous viruses showing >95% prevalence worldwide from early childhood, usually with asymptomatic primary infection. HHV-6 has been associated with many clinical conditions, but attempts to establish clear etiologic relationships with human disease have largely been confounded by the ubiquity of HHV-6 and the only relatively recent formal recognition of variants HHV-6A and HHV-6B. The most well-recognized clinical presentations of HHV-6 infections, roseola infantum and fever, occur as a result of primary infection mainly in otherwise healthy infants and young children. Primary infection in adults is uncommon. Severe syndromes typically result from HHV-6 reactivation in immunocompromised hosts. Most infections are caused by HHV-6B; disease attributed to HHV-6A is rare. Both of the HHV-6 variants and HHV-7 have been associated with disease in immunocompromised organ transplant recipients. HHV-8 stands out as being the only human herpesviruses with low prevalence in most of the world and is mainly known as the etiologic agent of Kaposi's sarcoma (KS). Like other herpesviruses, these viruses establish lifelong infections in their host and are maintained through a combination of latent (nonproductive) infections and intermittent or persistent lytic infections; consequently, they present diagnostic challenges.

Citation: Dollard S, Karnauchow T. 2016. Human Herpesviruses 6, 7, and 8, p 399-412. In Loeffelholz M, Hodinka R, Young S, Pinsky B (ed), Clinical Virology Manual, Fifth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819156.ch29
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

The photomicrograph depicts histopathologic changes seen in a human skin biopsy of Kaposi's sarcoma, most notably the appearance of the dermal layer with a cellular infiltrate and proliferation of vascular elements.

Citation: Dollard S, Karnauchow T. 2016. Human Herpesviruses 6, 7, and 8, p 399-412. In Loeffelholz M, Hodinka R, Young S, Pinsky B (ed), Clinical Virology Manual, Fifth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819156.ch29
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

The skin of a patient displaying characteristic reddish-brown cutaneous plaques indicative of Kaposi's sarcoma.

Citation: Dollard S, Karnauchow T. 2016. Human Herpesviruses 6, 7, and 8, p 399-412. In Loeffelholz M, Hodinka R, Young S, Pinsky B (ed), Clinical Virology Manual, Fifth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819156.ch29
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555819156.ch29
1. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B, Gallo RC. 1986. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596601.[PubMed]
2. Frenkel N, Schirmer EC, Wyatt LS, Katsafanas G, Roffman E, Danovich RM, June CH. 1990. Isolation of a new herpesvirus from human CD4+ T cells. Proc Natl Acad Sci USA 87:748752.[PubMed]
3. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:18651869. see comments.[PubMed]
4. Ablashi D, Agut H, Alvarez-Lafuente R, Clark DA, Dewhurst S, DiLuca D, Flamand L, Frenkel N, Gallo R, Gompels UA, Höllsberg P, Jacobson S, Luppi M, Lusso P, Malnati M, Medveczky P, Mori Y, Pellett PE, Pritchett JC, Yamanishi K, Yoshikawa T. 2014. Classification of HHV-6A and HHV-6B as distinct viruses. Arch Virol 159:863870.[PubMed]
5. De Bolle L, Van Loon J, De Clercq E, Naesens L. 2005. Quantitative analysis of human herpesvirus 6 cell tropism. J Med Virol 75:7685.[PubMed]
6. Ward KN, Leong HN, Thiruchelvam AD, Atkinson CE, Clark DA. 2007. Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis. J Clin Microbiol 45:12981304.[PubMed]
7. Luppi M, Marasca R, Barozzi P, Ferrari S, Ceccherini-Nelli L, Batoni G, Merelli E, Torelli G. 1993. Three cases of human herpesvirus-6 latent infection: integration of viral genome in peripheral blood mononuclear cell DNA. J Med Virol 40:4452.[PubMed]
8. Tanaka-Taya K, Sashihara J, Kurahashi H, Amo K, Miyagawa H, Kondo K, Okada S, Yamanishi K. 2004. Human herpesvirus 6 (HHV-6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA. J Med Virol 73:465473.[PubMed]
9. Arbuckle JH, Medveczky MM, Luka J, Hadley SH, Luegmayr A, Ablashi D, Lund TC, Tolar J, De Meirleir K, Montoya JG, Komaroff AL, Ambros PF, Medveczky PG. 2010. The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro. Proc Natl Acad Sci USA 107:55635568.[PubMed]
10. Goel P, Tailor P, Chande AG, Basu A, Mukhopadhyaya R. 2013. An infectious HHV-6B isolate from a healthy adult with chromosomally integrated virus and a reporter based relative viral titer assay. Virus Res 173:280285.[PubMed]
11. Gravel A, Hall CB, Flamand L. 2013. Sequence analysis of transplacentally acquired human herpesvirus 6 DNA is consistent with transmission of a chromosomally integrated reactivated virus. J Infect Dis 207:15851589.[PubMed]
12. Gerdemann U, Keukens L, Keirnan JM, Katari UL, Nguyen CTQ, de Pagter AP, Ramos CA, Kennedy-Nasser A, Gottschalk SM, Heslop HE, Brenner MK, Rooney CM, Leen AM. 2013. Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation. Blood 121:207218.[PubMed]
13. Pantry SN, Medveczky MM, Arbuckle JH, Luka J, Montoya JG, Hu J, Renne R, Peterson D, Pritchett JC, Ablashi DV, Medveczky PG. 2013. Persistent human herpesvirus-6 infection in patients with an inherited form of the virus. J Med Virol 85:19401946.[PubMed]
14. Wyatt LS, Frenkel N. 1992. Human herpesvirus 7 is a constitutive inhabitant of adult human saliva. J Virol 66:32063209.[PubMed]
15. Lusso P, Secchiero P, Crowley RW, Garzino-Demo A, Berneman ZN, Gallo RC. 1994. CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus. Proc Natl Acad Sci USA 91:38723876.[PubMed]
16. Giraldo G, Beth E, Haguenau F. 1972. Herpes-type virus particles in tissue culture of Kaposi's sarcoma from different geographic regions. J Natl Cancer Inst 49:15091526.[PubMed]
17. Beral V, Peterman TA, Berkelman RL, Jaffe HW. 1990. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 335:123128.[PubMed]
18. Neipel F, Fleckenstein B. 1999. The role of HHV-8 in Kaposi's sarcoma. Semin Cancer Biol 9:151164.[PubMed]
19. Moore PS, Chang Y. 2003. Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? Annu Rev Microbiol 57:609639.[PubMed]
20. Blackbourn DJ, Lennette E, Klencke B, Moses A, Chandran B, Weinstein M, Glogau RG, Witte MH, Way DL, Kutzkey T, Herndier B, Levy JA. 2000. The restricted cellular host range of human herpesvirus 8. AIDS 14:11231133.[PubMed]
21. Wang FZ, Dahl H, Ljungman P, Linde A. 1999. Lymphoproliferative responses to human herpesvirus-6 variant A and variant B in healthy adults. J Med Virol 57:134139.[PubMed]
22. Zerr DM, Meier AS, Selke SS, Frenkel LM, Huang ML, Wald A, Rhoads MP, Nguy L, Bornemann R, Morrow RA, Corey L. 2005. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 352:768776.[PubMed]
23. Dewhurst S, McIntyre K, Schnabel K, Hall CB. 1993. Human herpesvirus 6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of U.S. infants. J Clin Microbiol 31:416418.[PubMed]
24. De Bolle L, Naesens L, De Clercq E. 2005. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 18:217245.[PubMed]
25. Bates M, Monze M, Bima H, Kapambwe M, Clark D, Kasolo FC, Gompels UA. 2009. Predominant human herpesvirus 6 variant A infant infections in an HIV-1 endemic region of Sub-Saharan Africa. J Med Virol 81:779789.[PubMed]
26. Suga S, Yoshikawa T, Kajita Y, Ozaki T, Asano Y. 1998. Prospective study of persistence and excretion of human herpesvirus-6 in patients with exanthem subitum and their parents. Pediatrics 102:900904.[PubMed]
27. Fujiwara N, Namba H, Ohuchi R, Isomura H, Uno F, Yoshida M, Nii S, Yamada M. 2000. Monitoring of human herpesvirus-6 and -7 genomes in saliva samples of healthy adults by competitive quantitative PCR. J Med Virol 61:208213.[PubMed]
28. Rhoads MP, Magaret AS, Zerr DM. 2007. Family saliva sharing behaviors and age of human herpesvirus-6B infection. J Infect 54:623626.[PubMed]
29. Ward KN, Gray JJ, Efstathiou S. 1989. Brief report: primary human herpesvirus 6 infection in a patient following liver transplantation from a seropositive donor. J Med Virol 28:6972.[PubMed]
30. Kusuhara K, Takabayashi A, Ueda K, Hidaka Y, Minamishima I, Take H, Fujioka K, Imai S, Osato T. 1997. Breast milk is not a significant source for early Epstein-Barr virus or human herpesvirus 6 infection in infants: a seroepidemiologic study in 2 endemic areas of human T-cell lymphotropic virus type I in Japan. Microbiol Immunol 41:309312.[PubMed]
31. Hall CB, Caserta MT, Schnabel KC, Boettrich C, McDermott MP, Lofthus GK, Carnahan JA, Dewhurst S. 2004. Congenital infections with human herpesvirus 6 (HHV6) and human herpesvirus 7 (HHV7). J Pediatr 145:472477.[PubMed]
32. Hall CB, Caserta MT, Schnabel KC, McDermott MP, Lofthus GK, Carnahan JA, Gilbert LM, Dewhurst S. 2006. Characteristics and acquisition of human herpesvirus (HHV) 7 infections in relation to infection with HHV-6. J Infect Dis 193:10631069.[PubMed]
33. Caserta MT, Hall CB, Schnabel K, Lofthus G, McDermott MP. 2007. Human herpesvirus (HHV)-6 and HHV-7 infections in pregnant women. J Infect Dis 196:12961303.[PubMed]
34. Cohen A, Wolf DG, Guttman-Yassky E, Sarid R. 2005. Kaposi's sarcoma-associated herpesvirus: clinical, diagnostic, and epidemiological aspects. Crit Rev Clin Lab Sci 42:101153.[PubMed]
35. Engels EA, Atkinson JO, Graubard BI, McQuillan GM, Gamache C, Mbisa G, Cohn S, Whitby D, Goedert JJ. 2007. Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis 196:199207.[PubMed]
36. Cannon MJ, Dollard SC, Smith DK, Klein RS, Schuman P, Rich JD, Vlahov D, Pellett PE HIV Epidemiology Research Study Group. 2001. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med 344:637643.[PubMed]
37. Atkinson JO, Biggar RJ, Goedert JJ, Engels EA. 2004. The incidence of Kaposi sarcoma among injection drug users with AIDS in the United States. J Acquir Immune Defic Syndr 37:12821287.[PubMed]
38. Hladik W, Dollard SC, Mermin J, Fowlkes AL, Downing R, Amin MM, Banage F, Nzaro E, Kataaha P, Dondero TJ, Pellett PE, Lackritz EM. 2006. Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med 355:13311338.[PubMed]
39. Lebbé C, Legendre C, Francès C. 2008. Kaposi sarcoma in transplantation. Transplant Rev (Orlando) 22:252261.[PubMed]
40. Piselli P, Busnach G, Citterio F, Frigerio M, Arbustini E, Burra P, Pinna AD, Bresadola V, Ettorre GM, Baccarani U, Buda A, Lauro A, Zanus G, Cimaglia C, Spagnoletti G, Lenardon A, Agozzino M, Gambato M, Zanfi C, Miglioresi L, Di Gioia P, Mei L, Ippolito G, Serraino D Immunosuppression and Cancer Study Group. 2009. Risk of Kaposi sarcoma after solid-organ transplantation: multicenter study in 4,767 recipients in Italy, 1970–2006. Transplant Proc 41:12271230.[PubMed]
41. Ariza-Heredia EJ, Razonable RR. 2011. Human herpes virus 8 in solid organ transplantation. Transplantation 92:837844.[PubMed]
42. Pruksananonda P, Hall CB, Insel RA, McIntyre K, Pellett PE, Long CE, Schnabel KC, Pincus PH, Stamey FR, Dambaugh TR, Stewart JA. 1992. Primary human herpesvirus 6 infection in young children. N Engl J Med 326:14451450.[PubMed]
43. Hall CB, Long CE, Schnabel KC, Caserta MT, McIntyre KM, Costanzo MA, Knott A, Dewhurst S, Insel RA, Epstein LG. 1994. Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med 331:432438.[PubMed]
44. Tesini BL, Epstein LG, Caserta MT. 2014. Clinical impact of primary infection with roseoloviruses. Curr Opin Virol 9:9196.[PubMed]
45. Caserta MT, Hall CB, Canfield RL, Davidson P, Lofthus G, Schnabel K, Carnahan J, Shelley L, Wang H. 2014. Early developmental outcomes of children with congenital HHV-6 infection. Pediatrics 134:11111118.[PubMed]
46. Voumvourakis KI, Kitsos DK, Tsiodras S, Petrikkos G, Stamboulis E. 2010. Human herpesvirus 6 infection as a trigger of multiple sclerosis. Mayo Clin Proc 85:10231030.[PubMed]
47. Fotheringham J, Donati D, Akhyani N, Fogdell-Hahn A, Vortmeyer A, Heiss JD, Williams E, Weinstein S, Bruce DA, Gaillard WD, Sato S, Theodore WH, Jacobson S. 2007. Association of human herpesvirus-6B with mesial temporal lobe epilepsy. PLoS Medicine 4:0848–0857.
48. Ljungman P, Singh N. 2006. Human herpesvirus-6 infection in solid organ and stem cell transplant recipients. Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 37:(Suppl 1) S8791.
49. Lautenschlager I, Razonable RR. 2012. Human herpesvirus-6 infections in kidney, liver, lung, and heart transplantation: review. Transpl Int 25:493502.[PubMed]
50. Zerr DM. 2012. Human herpesvirus 6 (HHV-6) disease in the setting of transplantation. Curr Opin Infect Dis 25:438444.[PubMed]
51. Lee SO, Brown RA, Razonable RR. 2012. Chromosomally integrated human herpesvirus-6 in transplant recipients. Transpl Infect Dis 14:346354.[PubMed]
52. Zerr DM, Fann JR, Breiger D, Boeckh M, Adler AL, Xie H, Delaney C, Huang ML, Corey L, Leisenring WM. 2011. HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients. Blood 117:52435249.[PubMed]
53. Zerr DM. 2006. Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation. Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 37:(Suppl 1)S5256.
54. Hill JA, Boeckh MJ, Sedlak RH, Jerome KR, Zerr DM. 2014. Human herpesvirus 6 can be detected in cerebrospinal fluid without associated symptoms after allogeneic hematopoietic cell transplantation. J Clin Virol 61:289292.[PubMed]
55. Razonable RR. 2010. Infections due to human herpesvirus 6 in solid organ transplant recipients. Curr Opin Organ Transplant 15:671675.[PubMed]
56. Sassenscheidt J, Rohayem J, Illmer T, Bandt D. 2006. Detection of β-herpesviruses in allogenic stem cell recipients by quantitative real-time PCR. J Virol Methods 138:4048.[PubMed]
57. Razonable RR. 2013. Human herpesviruses 6, 7 and 8 in solid organ transplant recipients. Am J Transplant 13(Suppl 3):6777.[PubMed]
58. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. 1998. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 338:948954.[PubMed]
59. Cesarman E. 2011. Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients. Cancer Lett 305:163174.[PubMed]
60. Ablashi DV, Chatlynne LG, Whitman JE Jr, Cesarman E. 2002. Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev 15:439464.[PubMed]
61. Endo A, Watanabe K, Ohye T, Suzuki K, Matsubara T, Shimizu N, Kurahashi H, Yoshikawa T, Katano H, Inoue N, Imai K, Takagi M, Morio T, Mizutani S. 2014. Molecular and virological evidence of viral activation from chromosomally integrated human herpesvirus 6A in a patient with X-linked severe combined immunodeficiency. Clin Infect Dis 59:545548.[PubMed]
62. Fernández-Ruiz M, Kumar D, Husain S, Lilly L, Renner E, Mazzulli T, Moussa G, Humar A. 2015. Utility of a monitoring strategy for human herpesviruses 6 and 7 viremia after liver transplantation: a randomized clinical trial. Transplantation 99:106113.[PubMed]
63. Hakacova N, Klingel K, Kandolf R, Engdahl E, Fogdell-Hahn A, Higgins T. 2013. First therapeutic use of Artesunate in treatment of human herpesvirus 6B myocarditis in a child. J Clin Virol 57:157160.[PubMed]
64. Papadopoulou A, Gerdemann U, Katari UL, Tzannou I, Liu H, Martinez C, Leung K, Carrum G, Gee AP, Vera JF, Krance RA, Brenner MK, Rooney CM, Heslop HE, Leen AM. 2014. Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT. Sci Transl Med 6:242ra83.[PubMed]
65. Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, Biggar RJ HIV/AIDS Cancer Match Study. 2006. Trends in cancer risk among people with AIDS in the United States 1980–2002. AIDS 20:16451654.[PubMed]
66. Di Lorenzo G, Konstantinopoulos PA, Pantanowitz L, Di Trolio R, De Placido S, Dezube BJ. 2007. Management of AIDS-related Kaposi's sarcoma. Lancet Oncol 8:167176.[PubMed]
67. Carbone A, Vaccher E, Gloghini A, Pantanowitz L, Abayomi A, de Paoli P, Franceschi S. 2014. Diagnosis and management of lymphomas and other cancers in HIV-infected patients. Nat Rev Clin Oncol 11:223238.[PubMed]
68. La Ferla L, Pinzone MR, Nunnari G, Martellotta F, Lleshi A, Tirelli U, De Paoli P, Berretta M, Cacopardo B. 2013. Kaposi's sarcoma in HIV-positive patients: the state of art in the HAART-era. Eur Rev Med Pharmacol Sci 17:23542365.[PubMed]
69. Robey RC, Bower M. 2015. Facing up to the ongoing challenge of Kaposi's sarcoma. Curr Opin Infect Dis 28:3140.[PubMed]
70. Riva G, Luppi M, Barozzi P, Forghieri F, Potenza L. 2012. How I treat HHV8/KSHV-related diseases in posttransplant patients. Blood 120:41504159.[PubMed]
71. Le J, Gantt S AST Infectious Diseases Community of Practice. 2013. Human herpesvirus 6, 7 and 8 in solid organ transplantation. Am J Transplant 13(Suppl 4):128137.[PubMed]
72. Piselli P, Serraino D, Segoloni GP, Sandrini S, Piredda GB, Scolari MP, Rigotti P, Busnach G, Messa P, Donati D, Schena FP, Maresca MC, Tisone G, Veroux M, Sparacino V, Pisani F, Citterio F Immunosuppression and Cancer Study Group. 2013. Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997–2009. Eur J Cancer 49:336344.[PubMed]
73. Stock PG, Barin B, Murphy B, Hanto D, Diego JM, Light J, Davis C, Blumberg E, Simon D, Subramanian A, Millis JM, Lyon GM, Brayman K, Slakey D, Shapiro R, Melancon J, Jacobson JM, Stosor V, Olson JL, Stablein DM, Roland ME. 2010. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med 363:20042014.[PubMed]
74. Mori Y, Yamanishi K., 2007. HHV-6A, 6B, and 7: Pathogenesis, host response, and clinical disease, p 833842. In Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roisman B, Whitley R, Yamanishi K (eds), Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, Cambridge University Press, Cambridge.
75. Asano Y, Nakashima T, Yoshikawa T, Suga S, Yazaki T. 1991. Severity of human herpesvirus-6 viremia and clinical findings in infants with exanthem subitum. J Pediatr 118:891895.[PubMed]
76. Suga S, Yoshikawa T, Asano Y, Nakashima T, Yazaki T, Fukuda M, Kojima S, Matsuyama T, Ono Y, Oshima S. 1992. IgM neutralizing antibody responses to human herpesvirus-6 in patients with exanthem subitum or organ transplantation. Microbiol Immunol 36:495506.[PubMed]
77. Navalpotro D, Gimeno C, Navarro D. 2006. Concurrent detection of human herpesvirus type 6 and measles-specific IgMs during acute exanthematic human parvovirus B19 infection. J Med Virol 78:14491451.[PubMed]
78. Dahl H, Linde A, Sundqvist VA, Wahren B. 1990. An enzyme-linked immunosorbent assay for IgG antibodies to human herpes virus 6. J Virol Methods 29:313323.[PubMed]
79. Sloots TP, Kapeleris JP, Mackay IM, Batham M, Devine PL. 1996. Evaluation of a commercial enzyme-linked immunosorbent assay for detection of serum immunoglobulin G response to human herpesvirus 6. J Clin Microbiol 34:675679.[PubMed]
80. Ward KN, Gray JJ, Fotheringham MW, Sheldon MJ. 1993. IgG antibodies to human herpesvirus-6 in young children: changes in avidity of antibody correlate with time after infection. J Med Virol 39:131138.[PubMed]
81. Ward KN, Leong HN, Nacheva EP, Howard J, Atkinson CE,. 1571–1574. Davies NWS, Griffiths PD, Clark DA. 2006. Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles. J Clin Microbiol 44:1571–1574.
82. Cassina G, Russo D, De Battista D, Broccolo F, Lusso P, Malnati MS. 2013. Calibrated real-time polymerase chain reaction for specific quantitation of HHV-6A and HHV-6B in clinical samples. J Virol Methods 189:172179.[PubMed]
83. Nitsche A, Müller CW, Radonić A, Landt O, Ellerbrok H, Pauli G, Siegert W. 2001. Human herpesvirus 6A DNA Is detected frequently in plasma but rarely in peripheral blood leukocytes of patients after bone marrow transplantation. J Infect Dis 183:130133.[PubMed]
84. Razonable RR, Fanning C, Brown RA, Espy MJ, Rivero A, Wilson J, Kremers W, Smith TF, Paya CV. 2002. Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts. J Infect Dis 185:110113.[PubMed]
85. Safronetz D, Humar A, Tipples GA. 2003. Differentiation and quantitation of human herpesviruses 6A, 6B and 7 by real-time PCR. J Virol Methods 112:99105.[PubMed]
86. Reddy S, Manna P. 2005. Quantitative detection and differentiation of human herpesvirus 6 subtypes in bone marrow transplant patients by using a single real-time polymerase chain reaction assay. Biol Blood Marrow Transplant 11:530541.[PubMed]
87. Boutolleau D, Duros C, Bonnafous P, Caïola D, Karras A, Castro ND, Ouachée M, Narcy P, Gueudin M, Agut H, Gautheret-Dejean A. 2006. Identification of human herpesvirus 6 variants A and B by primer-specific real-time PCR may help to revisit their respective role in pathology. J Clin Virol 35:257263.[PubMed]
88. Flamand L, Gravel A, Boutolleau D, Alvarez-Lafuente R, Jacobson S, Malnati MS, Kohn D, Tang YW, Yoshikawa T, Ablashi D. 2008. Multicenter comparison of PCR assays for detection of human herpesvirus 6 DNA in serum. J Clin Microbiol 46:27002706.[PubMed]
89. de Pagter PJ, Schuurman R, de Vos NM, Mackay W, van Loon AM. 2010. Multicenter external quality assessment of molecular methods for detection of human herpesvirus 6. J Clin Microbiol 48:25362540.[PubMed]
90. Mannonen L, Loginov R, Helanterä I, Dumoulin A, Vilchez RA, Cobb B, Hirsch HH, Lautenschlager I. 2014. Comparison of two quantitative real-time CMV-PCR tests calibrated against the 1st WHO international standard for viral load monitoring of renal transplant patients. J Med Virol 86:576584.[PubMed]
91. Hall Sedlak R, Jerome KR. 2014. The potential advantages of digital PCR for clinical virology diagnostics. Expert Rev Mol Diagn 14:501507.[PubMed]
92. Leibovitch EC, Brunetto GS, Caruso B, Fenton K, Ohayon J, Reich DS, Jacobson S. 2014. Coinfection of human herpesviruses 6A (HHV-6A) and HHV-6B as demonstrated by novel digital droplet PCR assay. PLoS One 9:e92328.[PubMed]
93. Achour A, Boutolleau D, Slim A, Agut H, Gautheret-Dejean A. 2007. Human herpesvirus-6 (HHV-6) DNA in plasma reflects the presence of infected blood cells rather than circulating viral particles. J Clin Virol 38:280285.[PubMed]
94. Ihira M, Enomoto Y, Kawamura Y, Nakai H, Sugata K, Asano Y, Tsuzuki M, Emi N, Goto T, Miyamura K, Matsumoto K, Kato K, Takahashi Y, Kojima S, Yoshikawa T. 2012. Development of quantitative RT-PCR assays for detection of three classes of HHV-6B gene transcripts. J Med Virol 84:13881395.[PubMed]
95. Bressollette-Bodin C, Nguyen TVH, Illiaquer M, Besse B, Peltier C, Chevallier P, Imbert-Marcille BM. 2014. Quantification of two viral transcripts by real time PCR to investigate human herpesvirus type 6 active infection. J Clin Virol 59:9499.[PubMed]
96. Zerr DM, Boeckh M, Delaney C, Martin PJ, Xie H, Adler AL, Huang ML, Corey L, Leisenring WM. 2012. HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation. Biol Blood Marrow Transplant 18:17001708.[PubMed]
97. Hall CB, Caserta MT, Schnabel K, Shelley LM, Marino AS, Carnahan JA, Yoo C, Lofthus GK, McDermott MP. 2008. Chromosomal integration of human herpesvirus 6 is the major mode of congenital human herpesvirus 6 infection. Pediatrics 122:513520.[PubMed]
98. Géraudie B, Charrier M, Bonnafous P, Heurté D, Desmonet M, Bartoletti MA, Penasse C, Agut H, Gautheret-Dejean A. 2012. Quantitation of human herpesvirus-6A, -6B and -7 DNAs in whole blood, mononuclear and polymorphonuclear cell fractions from healthy blood donors. J Clin Virol 53:151155.[PubMed]
99. Boutolleau D, Fernandez C, André E, Imbert-Marcille BM, Milpied N, Agut H, Gautheret-Dejean A. 2003. Human herpesvirus (HHV)-6 and HHV-7: two closely related viruses with different infection profiles in stem cell transplantation recipients. J Infect Dis 187:179186.[PubMed]
100. Ogata M, Satou T, Kawano R, Goto K, Ikewaki J, Kohno K, Ando T, Miyazaki Y, Ohtsuka E, Saburi Y, Saikawa T, Kadota JI. 2008. Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation. Bone Marrow Transplant 41:279285.[PubMed]
101. Hill JA, Sedlak RH, Jerome KR. 2014. Past, present, and future perspectives on the diagnosis of Roseolovirus infections. Curr Opin Virol 9:8490.[PubMed]
102. Betts BC, Young JAH, Ustun C, Cao Q, Weisdorf DJ. 2011. Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary? Biol Blood Marrow Transplant 17:15621568.[PubMed]
103. Pellett PE, Ablashi DV, Ambros PF, Agut H, Caserta MT, Descamps V, Flamand L, Gautheret-Dejean A, Hall CB, Kamble RT, Kuehl U, Lassner D, Lautenschlager I, Loomis KS, Luppi M, Lusso P, Medveczky PG, Montoya JG, Mori Y, Ogata M, Pritchett JC, Rogez S, Seto E, Ward KN, Yoshikawa T, Razonable RR. 2012. Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol 22:144155.[PubMed]
104. Zerr DM, Gupta D, Huang ML, Carter R, Corey L. 2002. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis 34:309317.[PubMed]
105. Seeley WW, Marty FM, Holmes TM, Upchurch K, Soiffer RJ, Antin JH, Baden LR, Bromfield EB. 2007. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology 69:156165.[PubMed]
106. Hall CB, Caserta MT, Schnabel KC, Long C, Epstein LG, Insel RA, Dewhurst S. 1998. Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin Infect Dis 26:132137.[PubMed]
107. Hirabayashi K, Nakazawa Y, Katsuyama Y, Yanagisawa T, Saito S, Yoshikawa K, Shigemura T, Sakashita K, Ichikawa M, Koike K. 2013. Successful ganciclovir therapy in a patient with human herpesvirus-6 encephalitis after unrelated cord blood transplantation: usefulness of longitudinal measurements of viral load in cerebrospinal fluid. Infection 41:219223.[PubMed]
108. Nefzi F, Ben Salem NA, Khelif A, Feki S, Aouni M, Gautheret-Dejean A. 2015. Quantitative analysis of human herpesvirus-6 and human cytomegalovirus in blood and saliva from patients with acute leukemia. J Med Virol 87:451460.[PubMed]
109. Caserta MT, Hall CB, Schnabel K, Lofthus G, Marino A, Shelley L, Yoo C, Carnahan J, Anderson L, Wang H. 2010. Diagnostic assays for active infection with human herpesvirus 6 (HHV-6). J Clin Virol 48:5557.[PubMed]
110. Van den Bosch G, Locatelli G, Geerts L, Fagà G, Ieven M, Goossens H, Bottiger D, Öberg B, Lusso P, Berneman ZN. 2001. Development of reverse transcriptase PCR assays for detection of active human herpesvirus 6 infection. J Clin Microbiol 39:23082310.[PubMed]
111. Black JB, Schwarz TF, Patton JL, Kite-Powell K, Pellett PE, Wiersbitzky S, Bruns R, Müller C, Jäger G, Stewart JA. 1996. Evaluation of immunoassays for detection of antibodies to human herpesvirus 7. Clin Diagn Lab Immunol 3:7983.[PubMed]
112. Fernández-Ruiz M, López-Medrano F, Allende LM, Andrés A, Paz-Artal E, Aguado JM. 2014. Assessing the risk of de novo malignancy in kidney transplant recipients: role for monitoring of peripheral blood lymphocyte populations. Transplantation 98:e36e37.[PubMed]
113. Boivin G, Côté S, Cloutier N, Abed Y, Maguigad M, Routy JP. 2002. Quantification of human herpesvirus 8 by real-time PCR in blood fractions of AIDS patients with Kaposi's sarcoma and multicentric Castleman's disease. J Med Virol 68:399403.[PubMed]
114. Pellett PE, Wright DJ, Engels EA, Ablashi DV, Dollard SC, Forghani B, Glynn SA, Goedert JJ, Jenkins FJ, Lee TH, Neipel F, Todd DS, Whitby D, Nemo GJ, Busch MP Retrovirus Epidemiology Donor Study. 2003. Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion 43:12601268.[PubMed]
115. Laney AS, Cannon MJ, Jaffe HW, Offermann MK, Ou CY, Radford KW, Patel MM, Spira TJ, Gunthel CJ, Pellett PE, Dollard SC. 2007. Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi's sarcoma. AIDS 21:15411545.[PubMed]
116. Cannon MJ, Dollard SC, Black JB, Edlin BR, Hannah C, Hogan SE, Patel MM, Jaffe HW, Offermann MK, Spira TJ, Pellett PE, Gunthel CJ. 2003. Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus. AIDS 17:215222.[PubMed]
117. Engels EA, Whitby D, Goebel PB, Stossel A, Waters D, Pintus A, Contu L, Biggar RJ, Goedert JJ. 2000. Identifying human herpesvirus 8 infection: performance characteristics of serologic assays. J Acquir Immune Defic Syndr 23:346354.[PubMed]
118. Chandran B, Smith MS, Koelle DM, Corey L, Horvat R, Goldstein E. 1998. Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs. Virology 243:208217.[PubMed]
119. Biggar RJ, Engels EA, Whitby D, Kedes DH, Goedert JJ. 2003. Antibody reactivity to latent and lytic antigens to human herpesvirus-8 in longitudinally followed homosexual men. J Infect Dis 187:1218.[PubMed]
120. Lennette ET, Blackbourn DJ, Levy JA. 1996. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 348:858861.[PubMed]
121. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. 1996. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 2:918924.[PubMed]
122. Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao SJ, Bohenzky RA, Simmonds P, Lee C, de Ruiter A, Hatzakis A, Tedder RS, Weller IV, Weiss RA, Moore PS. 1996. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 348:11331138.[PubMed]
123. Schatz O, Monini P, Bugarini R, Neipel F, Schulz TF, Andreoni M, Erb P, Eggers M, Haas J, Buttò S, Lukwiya M, Bogner JR, Yaguboglu S, Sheldon J, Sarmati L, Goebel FD, Hintermaier R, Enders G, Regamey N, Wernli M, Stürzl M, Rezza G, Ensoli B. 2001. Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays. J Med Virol 65:123132.[PubMed]
124. Nascimento MC, de Souza VA, Sumita LM, Freire W, Weiss HA, Sabino EC, Franceschi S, Pannuti CS, Mayaud P. 2008. Prevalence of, and risk factors for Kaposi's sarcoma-associated herpesvirus infection among blood donors in Brazil: a multi-center serosurvey. J Med Virol 80:12021210.[PubMed]
125. Labo N, Miley W, Marshall V, Gillette W, Esposito D, Bess M, Turano A, Uldrick T, Polizzotto MN, Wyvill KM, Bagni R, Yarchoan R, Whitby D. 2014. Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteome. PLoS Pathog 10:e1004046.[PubMed]
126. Katano H, Sato Y, Kurata T, Mori S, Sata T. 2000. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. Virology 269:335344.[PubMed]
127. Chadburn A, Wilson J, Wang YL. 2013. Molecular and immunohistochemical detection of Kaposi sarcoma herpesvirus/human herpesvirus-8. Methods Mol Biol 999:245256.[PubMed]
128. Benevenuto de Andrade BA, Ramírez-Amador V, Anaya-Saavedra G, Martínez-Mata G, Fonseca FP, Graner E, Paes de Almeida O. 2014. Expression of PROX-1 in oral Kaposi's sarcoma spindle cells. J Oral Pathol Med 43:132136.[PubMed]
129. White IE, Campbell TB. 2000. Quantitation of cell-free and cell-associated Kaposi's sarcoma-associated herpesvirus DNA by real-time PCR. J Clin Microbiol 38:19921995.[PubMed]
130. Stamey FR, Patel MM, Holloway BP, Pellett PE. 2001. Quantitative, fluorogenic probe PCR assay for detection of human herpesvirus 8 DNA in clinical specimens. J Clin Microbiol 39:35373540.[PubMed]
131. de Sanjosé S, Marshall V, Solà J, Palacio V, Almirall R, Goedert JJ, Bosch FX, Whitby D. 2002. Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain. Int J Cancer 98:155158.[PubMed]
132. Pauk J, Huang ML, Brodie SJ, Wald A, Koelle DM, Schacker T, Celum C, Selke S, Corey L. 2000. Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 343:13691377.[PubMed]
133. Campbell TB, Borok M, Gwanzura L, MaWhinney S, White IE, Ndemera B, Gudza I, Fitzpatrick L, Schooley RT. 2000. Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage. AIDS 14:21092116.[PubMed]
134. Engels EA, Biggar RJ, Marshall VA, Walters MA, Gamache CJ, Whitby D, Goedert JJ. 2003. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma. AIDS 17:18471851.[PubMed]
135. Engelmann I, Petzold DR, Kosinska A, Hepkema BG, Schulz TF, Heim A. 2008. Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpes virus 6 DNA in blood and other clinical specimens. J Med Virol 80:467–477.

Tables

Generic image for table
TABLE 1

Laboratory diagnosis of HHV-6

Citation: Dollard S, Karnauchow T. 2016. Human Herpesviruses 6, 7, and 8, p 399-412. In Loeffelholz M, Hodinka R, Young S, Pinsky B (ed), Clinical Virology Manual, Fifth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819156.ch29
Generic image for table
TABLE 2

Laboratory diagnosis of HHV-8

Citation: Dollard S, Karnauchow T. 2016. Human Herpesviruses 6, 7, and 8, p 399-412. In Loeffelholz M, Hodinka R, Young S, Pinsky B (ed), Clinical Virology Manual, Fifth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819156.ch29

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error